88R15237 JSC-D     By: Talarico H.B. No. 4801       A BILL TO BE ENTITLED   AN ACT   relating to the use of the money in the Opioid Abatement Account.          BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:          SECTION 1.  Section 403.505(d), Government Code, is amended   to read as follows:          (d)  A state agency may use money appropriated from the   account only to:                (1)  prevent opioid use disorder through   evidence-based education and prevention, such as school-based   prevention, early intervention, or health care services or programs   intended to reduce the risk of opioid use by school-age children;                (2)  support efforts to prevent or reduce deaths from   opioid overdoses or other opioid-related harms, including through   increasing the availability or distribution of naloxone or other   opioid antagonists for use by health care providers, first   responders, persons experiencing an opioid overdose, families,   schools, community-based service providers, social workers, or   other members of the public;                (3)  create and provide training on the treatment of   opioid addiction, including the treatment of opioid dependence with   each medication approved for that purpose by the United States Food   and Drug Administration, medical detoxification, relapse   prevention, patient assessment, individual treatment planning,   counseling, recovery supports, diversion control, and other best   practices;                (4)  provide opioid use disorder treatment for youths   and adults, with an emphasis on programs that provide a continuum of   care that includes screening and assessment for opioid use disorder   and co-occurring behavioral health disorders, early intervention,   contingency management, cognitive behavioral therapy, case   management, relapse management, counseling services, and   medication-assisted treatments;                (5)  provide patients suffering from opioid dependence   with access to all medications approved by the United States Food   and Drug Administration for the treatment of opioid dependence and   relapse prevention following opioid detoxification, including   opioid agonists, partial agonists, and antagonists;                (6)  support efforts to reduce the abuse or misuse of   addictive prescription medications, including tools used to give   health care providers information needed to protect the public from   the harm caused by improper use of those medications;                (7)  support treatment alternatives that provide both   psychosocial support and medication-assisted treatments in areas   with geographical or transportation-related challenges, including   providing access to mobile health services and telemedicine,   particularly in rural areas;                (8)  address:                      (A)  the needs of persons involved with criminal   justice; and                      (B)  rural county unattended deaths; [or]                (9)  purchase opioid antagonists in bulk from   manufacturers to decrease the price burden on organizations   distributing opioid antagonists to respond to opioid overdoses; or                (10)  further any other purpose related to opioid   abatement authorized by appropriation.          SECTION 2.  This Act takes effect immediately if it receives   a vote of two-thirds of all the members elected to each house, as   provided by Section 39, Article III, Texas Constitution.  If this   Act does not receive the vote necessary for immediate effect, this   Act takes effect September 1, 2023.